116 related articles for article (PubMed ID: 10532646)
1. Antiplatelet therapy: views from the experts.
Easton JD; Diener HC; Bornstein NM; Einhäupl K; Gent M; Kaste M; Sacco RL; Tijssen JG; van Gijn J
Neurology; 1999; 53(7 Suppl 4):S32-7. PubMed ID: 10532646
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
3. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
4. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
5. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
6. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; Vécsei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
7. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
8. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
10. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
11. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Thijs V; Lemmens R; Fieuws S
Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy in ischemic stroke.
Pongrácz E; Káposzta Z
Expert Rev Neurother; 2005 Jul; 5(4):541-9. PubMed ID: 16026237
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic and thrombolytic therapy for ischemic stroke.
Cornett O; Ocava LC; Singh M; Malhotra S; Rosenbaum DM
Cardiol Clin; 2008 May; 26(2):251-65, vii. PubMed ID: 18406998
[TBL] [Abstract][Full Text] [Related]
14. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
Lutsep HL
Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
[TBL] [Abstract][Full Text] [Related]
15. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
Biller J
J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
[TBL] [Abstract][Full Text] [Related]
16. MATCH results: implications for the internist.
Lutsep HL
Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
19. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
Cavendish JJ; Cramer SC; Graham GD
Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
